BLOOD CENTER RES FOUND INC has a total of 29 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are KOMED CO LTD, SANQUIN BLOEDVOORZIENING and THE ISRAEL INSTITUTE OF BIOLOGICAL RES IIBR.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 5 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Agriculture | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Measuring microorganism processes | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Analysing materials | |
#7 | Unspecified technologies | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Newman Peter J | 11 |
#2 | Wiedmer Therese | 8 |
#3 | Sims Peter J | 8 |
#4 | Aster Richard H | 5 |
#5 | Gumina Richard J | 5 |
#6 | Kirschbaum Nancy | 4 |
#7 | Visentin Gian | 3 |
#8 | Kunicki Thomas J | 3 |
#9 | Zhao Ji | 3 |
#10 | Boldt Benjamin W | 2 |
Publication | Filing date | Title |
---|---|---|
EP1047779A2 | Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system | |
US5972717A | Method and kit for detecting heparin induced thrombocytopenia | |
US5972718A | Method of detecting heparin-induced thrombocytopenia | |
US5917030A | Platelet cell adhesion molecule and variants thereof | |
US5668012A | Platelet endothelial cell adhesion molecule-1 promoters and uses thereof | |
US5837447A | Monitoring an immune response by analysis of amplified immunoglobulin or T-cell-receptor nucleic acid | |
US5468611A | Method for HLA typing | |
US5545526A | Method for HLA Typing | |
AU9143991A | Monoclonal antibody op-g2 and method of use | |
US5149787A | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |